News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Investor (World)
Actavis (ACT) Announces Closing Of Public Offerings Of Ordinary Shares And Mandatory Convertible Preferred Shares In Connection With Pending Acquisition Of Allergan (AGN) 3/3/2015
Mylan Inc. (MYL) Files Annual Report On Form 10-K For Year Ended Dec. 31, 2014 3/3/2015
Aviva Plc And Aviva Investors Global Services Limited Provide Notification Of A 5.02% Shareholding In Ablynx (ABLYF) 3/3/2015
Alnylam (ALNY)’s “Incredibly Deep” Pipeline Continues to Impress As Commercial Stage Looms, Says Analyst 3/2/2015
InMed Pharmaceuticals To Present Investor Webcast March 5 3/2/2015
Karolinska Development AB Confirms Full Payment In The Rights Issue Of Convertibles 3/2/2015
Actavis (ACT) Announces Proposed Public Offering Of Senior Notes In Connection With Pending Acquisition Of Allergan (AGN) 3/2/2015
Tianyin Pharmaceutical Co, Inc. Received Notice Of Non-Compliance With NYSE MKT Continued Listing Requirements 2/27/2015
Teva Pharmaceutical Industries (TEVA) Announces Early Results Of Debt Tender Offer, Pricing, Election Of Early Settlement And Increase In Maximum Amount And Priority 2 Notes Tender Cap 2/27/2015
Presentation Of The Result Of Medivir AB (MVRBF)’s Voluntary Redemption Programme 2/27/2015
Cortendo AB: Cortendo Announces Notice Of Extraordinary General Meeting 2/27/2015
Cardio3 BioSciences To Raise Capital Via A Private Placement Of New Shares 2/26/2015
Actavis (ACT) Announces Pricing Of Public Offerings Of Ordinary Shares And Mandatory Convertible Preferred Shares In Connection With Pending Acquisition Of Allergan (AGN) 2/25/2015
Alkermes plc (ALKS) Announces Webcast Of Analyst And Investor Event On March 2, 2015 2/24/2015
GENFIT Corp. (ALGFT): Minutes Of The Combined General Shareholders' Meeting Of February 24, 2015 2/24/2015
Fake Quote Scandal: Medical Marijuana Firm CEN Biotech Receives Major Setback 2/20/2015
RedHill Biopharma Ltd. (RDHL) Announces Full Exercise Of Underwriters' Over-Allotment Option 2/18/2015
RedHill Biopharma Ltd. (RDHL) Announces Closing Of Public Offering Of Its American Depository Shares 2/13/2015
VolitionRX Announces Closing Of Public Offering Of Common Stock 2/12/2015
Transition Therapeutics Inc. (TTH.TO) Announces Pricing Of Public Offering Of US$20 Million Of Common Shares 2/12/2015
BIOCEO15: Kite Pharma (KITE) Debuts Near-Term Plans, Says It’s Tackling "Toxicity Issues" 2/10/2015
BIOCEO15: New Report On Biotech Venture Capital Over Last 10 Years Finds Heavy Focus on R&D 2/10/2015
BIOCEO15: Sarepta (SRPT) CEO Feels Backlash After Saying Ebola Research Isn’t in "Shareholder Interest" 2/10/2015
RedHill Biopharma Ltd. (RDHL) Prices Public Offering Of Its American Depository Shares 2/10/2015
RedHill Biopharma Ltd. (RDHL) Announces Proposed Public Offering Of Its American Depository Shares 2/10/2015
Suven Life Sciences Ltd Revenue Growth At 9% While PAT Is Down By 11.55% For The 3rd Quarter Ended Dec 2014 2/10/2015
BIOCEO15: Financial Panel Sees Deal-Making Up in 2015, Names CAR-T, Plaque Attackers as Hot Targets 2/9/2015
BNP Paribas Notify Of 5.08% Shareholding In Galapagos NV (GLPG.BR) 2/9/2015
VolitionRX Prices Public Offering of Common Stock 2/6/2015
Genmab A/S (GEN.CO) Release: Major Shareholder Announcement 2/5/2015
Express Scripts Inc. Cheers As Data Shows Drug Pricing Up 3-Fold, Even When Adjusted For Inflation, Survival 2/5/2015
Macrocure (MCUR) Announces Special General Meeting Of Shareholders For Approval Of Amendments To Compensation Package Of CEO And 2013 Share Incentive Plan 2/5/2015
Alkermes plc (ALKS)’ Corporate Presentation To Be Webcast At Two Upcoming Conferences 2/4/2015
Forget Smartphones—Genomic Data is the Next Big Deal, Says Edico Genome CEO 2/4/2015
Summit Corporation Files Registration Statement For Proposed U.S. Public Offering And Applies For NASDAQ Listing 2/2/2015
Admedus Release: Announcement To The Australian Stock Exchange 2/2/2015
Future Of Healthcare Investor Forum Highlights Investment Opportunity In UK Life Sciences 1/29/2015
Oxford Immunotec Limited (OXFD) Announces Proposed Underwritten Offering Of Ordinary Shares 1/29/2015
BioSpace (DHX)'s List of Five Companies to Watch in 2015: Aegerion (AEGR), AbbVie (ABBV), Tekmira (TKMR), Novartis AG (NVS), GlaxoSmithKline (GSK) 1/28/2015
Ascendis Pharma A/S Announces Pricing Of Initial Public Offering 1/28/2015
ESSA Pharma Inc. Lists On The TSX Venture Exchange 1/28/2015
AnaMar Announces Strategic Realignment And 2015 Corporate Priorities 1/28/2015
Oxford Immunotec Global PLC Announces Proposed Underwritten Offering Of Ordinary Shares 1/28/2015
Amgen (AMGN) Beats Street’s Earnings Estimates, Ready for Biosimilars, Says Citi 1/27/2015
Cortendo AB: Notification Of Trade 1/27/2015
Medivir AB (MVRBF)’s CEO Increases His Shareholding In The Company 1/27/2015
Scandal-Hit GlaxoSmithKline (GSK) to Chop 1,000 Staffers in China 1/27/2015
Ultimovacs Carries Out NOK 45 Million Share Issue With Canica AS And Sundt AS As The Main Investors 1/22/2015
Ablynx (ABLYF) Announces Warrant Exercise 1/21/2015
Endo International (ENDP) Announces Pricing of Private Offering Of Senior Notes 1/21/2015
Endo International (ENDP) Announces Proposed Private Offering Of Senior Notes 1/20/2015
NeuroDerm Ltd. (NDRM) Announces Extraordinary General Meeting Of Shareholders For Ratification Of Election Of External Directors And Adoption Of Compensation Policy 1/20/2015
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 1/20/2015
Horizon Discovery Group plc Trading Update 1/19/2015
Valeant (VRX) Announces Pricing Of Private Offering Of Senior Notes 1/16/2015
Cortendo AB: Cortendo Announces Notice Of Extraordinary General Meeting 1/15/2015
Alcobra (ADHD) Announces Closing Of Public Offering Of Ordinary Shares And Full Exercise Of Over-Allotment Option 1/14/2015
Debiopharm Diagnostics Leads Investment Round In GenePOC With Emerillon Capital 1/14/2015
ProSensa Holding N.V. (RNA) Announces Shareholder Approval Of Certain Matters Relating To The BioMarin (BMRN) Tender Offer 1/13/2015
Cardio3 BioSciences To Host Investor & Analyst Day In New York On Friday, January 30, 2015 1/13/2015
Pluristem Therapeutics (PSTI) Issues Letter To Shareholders 1/12/2015
MGB Biopharma Limited Continues To Progress Its Truly Novel Anti-Infectives Platform To Tackle Antibiotic Resistance In 2014 1/12/2015
Allergy Therapeutics plc Release: Trading Update 1/12/2015
Skyepharma PLC (SKYEF) Release: Pre-Close Update 1/12/2015
ERYtech Pharma Announces ADR Level 1 Listing In The U.S. 1/12/2015
Fountain Healthcare's New €85 Million Fund to Create New Jobs in Biotech, Medtech 1/9/2015
Alcobra (ADHD) Announces Commencement Of Public Offering Of Ordinary Shares 1/9/2015
Alcobra (ADHD) Prices Public Offering Of Ordinary Shares 1/9/2015
China Biologic Products Adopts Stockholder Rights Plan 1/9/2015
Seventure Invests EUR 1 M (USD 1.25 M) In First Investment Round For MaaT Pharma™ 1/9/2015
EXCLUSIVE: Developing World Needs Different Pricing Model, Naia Limited CEO Tells BioSpace (DHX) 1/9/2015
TRANSGENE (ENX:TNG) Announces Financial Calendar For 2015 1/8/2015
Fundamentals Still Strong for Large Cap Biotech, But Headwinds Remain 1/7/2015
Pivotal Therapeutics Inc. Announces Payment Of Interest On Outstanding Convertible Notes 1/6/2015
The FDA’s Breakthrough Therapy Program By the Numbers 1/5/2015
Protalix Biotherapeutics, Inc. (PLX) Announces New Strategy For Accelerated Growth 1/5/2015
RedHill Biopharma Ltd. (RDHL) Business Outlook And Anticipated Key Milestones For 2015 1/5/2015
Enzymotec Announces An Extraordinary General Meeting Of Shareholders 1/5/2015
Biotech Investors Surge Happily Into New Year, “Frothy” or Not, Says Cowen 1/5/2015
Tianyin Pharmaceutical Co, Inc. Updates on Alliance Discussion 1/2/2015
AmpliPhi Biosciences Corporation (APHB) To Host Shareholder Update Conference Call 12/31/2014
Share Buybacks Could Save Gilead Sciences, Inc. (GILD) After Turbulent Two Weeks, Says Citi 12/30/2014
Change Of Number Of Shares And Votes In Karolinska Development AB 12/30/2014
Change In Number Of Shares And Votes In Meda AB (MEDA-A.ST) 12/30/2014
Bloodbath On Wall Street Over Drug Pricing Will Taper, Says Analyst 12/23/2014
AbbVie (ABBV)’s Access to Express Scripts Inc. a “Pyrrhic Victory,” Says Analyst 12/22/2014
Covidien plc (COV) Declares Quarterly Cash Dividend 12/22/2014
GlaxoSmithKline (GSK) Reassure Investors That Dividend Is Safe As Analysts Question Payout 12/19/2014
AEterna Zentaris (AEZS) Receives Notification From NASDAQ Relating To Minimum Bid Price 12/19/2014
Biotech Predictions for Large Cap Firms Include Medivation, Inc. (MDVN), Gilead Sciences, Inc. (GILD) 12/18/2014
2015 Could Be Blockbuster Year for Alkermes plc (ALKS), Says Citi 12/17/2014
K-Bro Declares December Dividend 12/16/2014
The Biotech Year in Review, According To Bernstein 12/16/2014
China Cord Blood Corporation Announces Results of 2014 Annual General Meeting 12/11/2014
Analysts Not Sold On Medivation, Inc. (MDVN)’s Xtandi as Breast Cancer Drug 12/10/2014
bluebird bio (BLUE)’s New Blood Treatment Could Benefit Sickle Cell, Says Analyst 12/9/2014
Karolinska Development AB Release: Purchase Of Own Shares To Cover Social Security Fees Related To Incentive Program 12/8/2014
Survey of Investors, Hedge Funds Blasé on Merck & Co. (MRK), Cubist Pharmaceuticals, Inc. (CBST) Deal 12/8/2014
Rubicon Hints At ArborGen IPO, Laments Skidding Share Price 12/5/2014
Drug Spending Still Under 10% of American Health Costs, Says Analyst 12/5/2014
GlaxoSmithKline (GSK) Abandons Planned Sale Of Established Products Portfolio 12/5/2014
Speculation Mounts That Pfizer (PFE) Will Up Bid For AstraZeneca PLC (AZN) As Cooling Off Period Ends 12/5/2014
WuXi PharmaTech Co., Ltd. Subsidiary Submits Application To The National Equities Exchange And Quotations In China To List On The New Third Board 12/4/2014
BTG plc (BTG.L) Results Of Placing 12/4/2014
Perrigo Company (PRGO) Announces The Closing Of Its Registered Public Offering Of Senior Notes 12/3/2014
DelMar Pharmaceuticals Joins OTCQX 12/3/2014
Is New Alzheimer’s Drug the Stabilizing Force Biogen Idec (BIIB) Needs? 12/3/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data 12/3/2014
Teva Pharmaceutical Industries Limited (TEVA) To Host 2015 Business Outlook Conference Call And Webcast On December 11, 2014 12/2/2014
Valeant (VRX) Announces Redemption Of US$445.0 Million Aggregate Principal Amount Of Its Outstanding 6.875% Senior Notes Due 2018 12/1/2014
Immune Pharmaceuticals, Inc. Completes Underwriter's Exercise Of Partial Over-Allotment Option 12/1/2014
Roche Holdings, Inc. Announces Final Results Of Its Debt Tender Offer 12/1/2014
2015 Will Be A Defining Year for Gene Therapy, Says Analyst 12/1/2014
Cowen: With NASDAQ Index Up 33%, Biotech Remains a Winner 12/1/2014
e-Therapeutics plc Release: Research And Development Presentation To Investors And Analysts 12/1/2014
Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 11/26/2014
Cynapsus Therapeutics (CYNAF) Announces Uplisting To The Toronto Stock Exchange’s Senior Equity Market 11/26/2014
Alkermes plc (ALKS)’ Corporate Presentation To Be Webcast At The NASDAQ OMX 31st Investor Program 11/26/2014
Immune Pharmaceuticals, Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 11/26/2014
Analyst: First Quarter of 2015 Crucial to ProSensa Holding N.V. (RNA), BioMarin Pharmaceutical Inc. (BMRN) Deal 11/25/2014
Perrigo Company plc Announces The Pricing Of Senior Notes Offering By Its Finance Subsidiary, Perrigo Finance plc 11/25/2014
AVANIR Pharmaceuticals (AVNR) Making Strides With Alzheimer’s Drug, Says Analyst 11/24/2014
Tekmira (TKMR) Provides Key Highlights Of Analyst And Investor Day In New York 11/24/2014
Bayer AG (BAYZF) To Use IPO Funds To Cut Debt And Buy Consumer Drugs 11/24/2014
BioMarin Pharmaceutical Inc. (BMRN), ProSensa Holding N.V. (RNA) Marriage Makes Sense for Investors If Regulatory Hurdles Can Be Overcome 11/24/2014
Solid Lymphoma Data Points To Larger Potential For Epizyme (EPZM), Says Citi 11/21/2014
Perrigo Company Plc Announces The Pricing Of Its Offering Of Ordinary Shares 11/21/2014
uniQure To Host Investor Day In New York City 11/21/2014
Cowen: Acorda Therapeutics (ACOR) Not Worried About Civitas Therapeutics' New Parkinson's Drug 11/20/2014
LentiGlobin Looks Promising On Sickle Cell For bluebird bio (BLUE), Says Analyst 11/19/2014
Best Value In Biotech? Actavis (ACT), Says UBS 11/17/2014
Forward Pharma (FWP) Announces Closing Of Partial Exercise Of Over-Allotment Option 11/17/2014
Actavis (ACT) Successfully Completes Durata Therapeutics, Inc.  (DRTX) Tender Offer 11/17/2014
ISI: Merck & Co. (MRK)’s Zetia News The Rising Tide To Lift All LDL Boats 11/17/2014
If Investors Like Merck & Co. (MRK)'s Zetia Results, They Will Love Esperion Therapeutics, Inc. (ESPR)’s, Says Citi 11/17/2014
Cowen: Achaogen (AKAO)’s New Antibiotic Could Be Key to Solving Types of Drug Resistance 11/17/2014
Biotech Investors Bullish On Large Cap; Citi Adds Vertex Pharmaceuticals (MA) (VRTX), BioMarin Pharmaceutical Inc. (BMRN) and Tesaro, Inc. (TSRO) To Most Preferred 11/14/2014
Patent Fight Between Amgen (AMGN) And Sanofi (SAN.PA)/Regeneron (REGN) Getting Murkier, Says Analyst 11/14/2014
With Promising New Gout Treatment In Its Pipeline, 2015 Will Be Big Year For CymaBay Therapeutics 11/14/2014
Roche (RHHBY) Announces Early Tender Results Of Its Debt Tender Offer 11/13/2014
Analyst: Amgen (AMGN)’s Psoriasis Drug Is Superior To Stelara And Sales Will Reflect That 11/13/2014
Regeneron (REGN), Sanofi (SAN.PA) Asthma Drug A Potential Blockbuster For Allergies, Says Analyst 11/12/2014
Galmed Pharmaceuticals Provides Business Update And Reports Year-To-Date 2014 Financial Results 11/12/2014
Citi: Esperion Therapeutics, Inc. (ESPR) Will See Cancer Drug Data By End Of Year 11/11/2014
Gilead Sciences, Inc. (GILD) Poised To Be One Of The Most Remarkable Growth Stories In Biotech, Says Analyst 11/11/2014
Citi: Agios Pharmaceuticals (AGIO)’s Experimental Cancer Drug Could Provide Major Upside 11/10/2014
Analyst: Celgene (CELG)’s Drug Pipeline Will Be The Gift That Keeps On Giving 11/10/2014
GENFIT Corp. (ALGFT) To Participate In Three Upcoming Investor Conferences 11/7/2014
TherapeuticsMD, Inc.  (TXMD) Looking At Lower Cash Burn, Higher Upside From Promising HRT Therapies: Cowen 11/7/2014
Bristol-Myers Squibb Company (BMY), Merck & Co. (MRK) Competing Hodgkin’s Drugs Look Comparable, Says Analyst 11/7/2014
Sangui BioTech International Inc. (SGBI) Officially Approved As Trading On OTCQB 11/6/2014
Meda AB (MEDA-A.ST) Extraordinary General Meeting Bulletin 11/6/2014
Pharmacyclics, Inc. (PCYC), AstraZeneca PLC (AZN) Partnership Holds Tumor Promise: Citi 11/6/2014
Galmed Pharmaceuticals To Host Key Opinion Leader Meeting And Webcast On November 7, 2014 In New York City 11/5/2014
Karolinska Development AB Secures Funding From CP Group, A Leading Asian Life Science Investor, And Initiates Preparation For A Convertible Bond Issue 11/5/2014
NeuroDerm Announces Launch Of Initial Public Offering 11/4/2014
BioMarin Pharmaceutical Inc. (BMRN),Incyte Corporation (INCY) Part Of Rally As Biotech Sector Booms, Says Cowen 11/3/2014
Amgen (AMGN), Sandoz, Inc. Biosimilar War Could Provide Playbook, Says Analyst 10/31/2014
Novo Nordisk A/S (NVO) Commits $130 Million In Diabetes Research In Denmark 10/31/2014
Change In The Number Of Shares And Votes In Meda AB (MEDA-A.ST) 10/31/2014
AbbVie (ABBV) Might Go Shopping Again Despite Shire Breakup, Say Company Execs 10/31/2014
Citi: Gilead Sciences, Inc. (GILD) Sees Blockbuster First Weeks Of Harvoni Launch 10/31/2014
Synergy Pharmaceuticals Announces Full Exercise Of Over-Allotment Option 10/30/2014
Cowen: Amgen (AMGN)’s Plans Are “Music To Our Ears" 10/30/2014
Roche Holdings, Inc. Announces Debt Tender Offer 10/30/2014
Ebola Epidemic Unlikely But Not Impossible, Says Immunovaccine Inc. CEO 10/29/2014
Ampio Pharmaceuticals, Inc. (AMPE) Could Have A Blockbuster Fourth Quarter, Says Citi 10/29/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 10/29/2014
NeuroVive Pharmaceutical AB: Annual General Meeting 2015 And Information About Members Appointed To The Nomination Committee 10/29/2014
Merck & Co. (MRK) Execs “Downplaying” Gilead Sciences, Inc. (GILD)'s Harvoni Competitor, Says Analyst 10/28/2014
Nordic Nanovector – Registered Share Capital Increase 10/28/2014
Amgen (AMGN) Tells Analysts It Will Improve Margins 15% By Axing 4,000 Jobs 10/28/2014
Citi: Sarepta Therapeutics (SRPT) Will See Competition, Concern Over FDA Delay 10/27/2014
Nordic Nanovector: Issuance Of Shares To HealthCap VI L.P 10/24/2014
Strong Earnings Could Mean Buying Spree For Alexion Pharmaceuticals Inc. (ALXN), Says Analyst 10/24/2014
Ocera Therapeutics, Inc. (OCRX)’s New HE Drug Could Pull Stock Up Out Of Rut: Cowen 10/24/2014
Tug-Of-War Over Revlimid Patent Continues Between Celgene (CELG), Natco Pharma Limited 10/24/2014
Innocoll AG Proposes Changes To Supervisory Board And Stock Option Plan 10/23/2014
Celgene (CELG) Beats The Street Again On Earnings And Analysts Couldn’t Be Happier 10/23/2014
Hold Your Horses On Splicing Amgen (AMGN), Say Citi Analysts 10/22/2014
Ablynx (ABLYF) Announces Warrant Exercise 10/21/2014
Oncolytics Biotech Inc. (ONC.TO) Announces Amendment To Common Share Purchase Agreement With Lincoln Park Capital Fund, LLC 10/21/2014
Nine-Month Figures For 2014: Sartorius Grows In Order Intake, Sales Revenue And Earnings 10/21/2014
Tianyin Pharmaceutical Co, Inc. Received Notices Of Non-Compliance From NYSE MKT 10/21/2014
ISI Group: AbbVie (ABBV)’s Dividend, Repurchasing Attempt Could Mean More Debt 10/21/2014
Celgene (CELG)’s New Crohn’s Disease Drug Impressing Analysts 10/21/2014
DBV Technologies Announces Proposed Global Offering 10/20/2014
Meta-IQ Engages Back Bay Life Science Advisors In Preparation For Investment 10/20/2014
Sunshine Biopharma, Inc. Retains Renmark Financial Communications To Provide Investor Relations 10/17/2014
TiGenix Publishes Transparency Notification Pursuant To Article 14 Of The Law Of May 2, 2007 10/17/2014
Portage Completes Non-Brokered Private Placement For A Total Proceeds Of US$2,000,000 10/16/2014
Tianyin Pharmaceutical Co, Inc. Provides Update On Filing Of Form 10-K For Fiscal Year Ended June 30, 2014 10/15/2014
Orexo AB (ORXOF) Appoints Nomination Committee And Publishes Financial Calendar 2014/2015 10/15/2014
Announcement Regarding Submission Of Tender Offer For Shares In Ambit Biosciences 10/15/2014
UBS: Gilead Sciences, Inc. (GILD) Remains Solid Buy Despite Irish Tax Changes, Price War 10/15/2014
ChrysCapital In Talks With Private Equity Firms To Sell 11% In Mankind Pharma 10/15/2014
Immunodiagnostic Systems Holdings plc Trading Update 10/14/2014
Sunshine Biopharma, Inc. Retains Renmark Financial Communications To Provide Investor Relations 10/14/2014
Nextech Venture Invest Announces First Closing Of Oncology Fund IV 10/14/2014
Easton Pharmaceuticals (OP: EAPH) Secures Financing Commitment Towards Closing Of Its Option On Canadian Medical Marijuana Facility And Business 10/14/2014



//-->